BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 4018468)

  • 21. Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by EMS personnel without direct physician control.
    Furlong R; Gerhardt RT; Farber P; Schrank K; Willig R; Pittaluga J
    Am J Emerg Med; 1995 Jul; 13(4):383-8. PubMed ID: 7605518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amiodarone in the control of supraventricular tachyarrhythmias].
    Molina L; Heredia P; Pinto R; Mesa A; Villarreal A; GutiƩrrez Fuster E
    Arch Inst Cardiol Mex; 1983; 53(1):13-6. PubMed ID: 6191726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High-frequency electrostimulation of the atrium in therapy of atrial flutter in patients pre-treated with amiodarone].
    Suzzi G; Candelpergher G; Buchberger R; Simoncello P; Cernetti C
    G Ital Cardiol; 1982; 12(10):702-5. PubMed ID: 7182208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
    Bianconi L; Castro A; Dinelli M; Alboni P; Pappalardo A; Richiardi E; Santini M
    Eur Heart J; 2000 Aug; 21(15):1265-73. PubMed ID: 10924317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacologic cardioversion with intravenous amiodarone].
    Sannia L; Frau G; Dore L; Terrosu P; Ibba GV
    Boll Soc Ital Cardiol; 1981; 26(6):553-8. PubMed ID: 7347250
    [No Abstract]   [Full Text] [Related]  

  • 28. Amiodarone in the management of refractory atrial fibrillation.
    Blevins RD; Kerin NZ; Benaderet D; Frumin H; Faitel K; Jarandilla R; Rubenfire M
    Arch Intern Med; 1987 Aug; 147(8):1401-4. PubMed ID: 3307669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison between therapeutic effects of acupuncture and intravenous injection of amiodarone in the treatment of paroxymal atrial fibrillation and atrial flutter].
    Xu HK; Zhang YF
    Zhongguo Zhen Jiu; 2007 Feb; 27(2):96-8. PubMed ID: 17370488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repetitive supraventricular tachycardia: clinical manifestations and response to therapy with amiodarone.
    Haines DE; Lerman BB; DiMarco JP
    Pacing Clin Electrophysiol; 1986 Jan; 9(1 Pt 1):130-3. PubMed ID: 2419843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation].
    Krikler DM
    Minerva Med; 1975 May; 66(39):1914-22. PubMed ID: 236526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of atrial flutter and fibrillation with amiodarone and digitalis].
    Greco R; Musto B; De Martino U; Marsico F
    G Ital Cardiol; 1977; 7(7):706-12. PubMed ID: 902950
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
    Holt P; Crick JC; Davies DW; Curry P
    Int J Cardiol; 1985 May; 8(1):67-79. PubMed ID: 3997293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Four years of clinical experience with the cardio-eurhythmic action of verapamil in intravenous administration].
    Piccini A; Malfatti S
    Minerva Med; 1975 May; 66(39):1923-31. PubMed ID: 48221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate.
    Hofmann R; Steinwender C; Kammler J; Kypta A; Leisch F
    Int J Cardiol; 2006 Jun; 110(1):27-32. PubMed ID: 16046015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action.
    Sung RJ; Waxman HL; Elser B; Juma Z
    Clin Invest Med; 1980; 3(1-2):41-7. PubMed ID: 7009003
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response.
    Strasberg B; Arditti A; Sclarovsky S; Lewin RF; Buimovici B; Agmon J
    Int J Cardiol; 1985 Jan; 7(1):47-58. PubMed ID: 4055134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
    Stewart DE; Ikram H
    N Z Med J; 1984 Mar; 97(751):148-50. PubMed ID: 6584758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.